RECRUITING

Application of Virtual Reality Technology to Treatment of Social Anxiety

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to compare CBT VR exposure + VR social skills treatment to CBT Imaginal exposure + mindfulness, in reducing the severity of social anxiety in adults with autism and social anxiety (SA), to identify characteristics associated with benefitting from the CBT-VR treatment and to assess acceptability and feasibility of the VR intervention for patients receiving it and use findings to improve methods and to prepare for a community based pragmatic trial.

Official Title

Application of Virtual Reality Technology to Treatment of Social Anxiety

Quick Facts

Study Start:2024-11-07
Study Completion:2026-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06845488

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Autism Spectrum Disorder (ASD) (diagnosed by a qualified professional)
  2. * verbal and literate in English or Spanish
  3. * average or greater intellectual ability, based on history and interview
  4. * able to operate a computer (Windows or Mac).
  1. * current or historical severe mental illness such as schizophrenia, bipolar disorder, or severe depression
  2. * intellectual disability or a learning disability that would interfere with participating (e.g., unable to read)
  3. * unable use the technology or do not have access to the technology
  4. * unable to read

Contacts and Locations

Study Contact

Katherine Loveland, PhD
CONTACT
713-486-2587
Katherine.A.Loveland@uth.tmc.edu
Craig Motsenbocker, PhD
CONTACT
(713) 486-2700
craig.m.motsenbocker@uth.tmc.edu)

Principal Investigator

Katherine Loveland, PhD
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center at Houstom

Study Locations (Sites)

The University of Texas Health Science Center at Houston
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center, Houston

  • Katherine Loveland, PhD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center at Houstom

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-07
Study Completion Date2026-03-31

Study Record Updates

Study Start Date2024-11-07
Study Completion Date2026-03-31

Terms related to this study

Keywords Provided by Researchers

  • Virtual reality
  • psychotherapy

Additional Relevant MeSH Terms

  • Autism Spectrum Disorder
  • Social Anxiety Disorder